US Patent Issued to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on March 4 for "Pharmaceutical composition comprising expression or activity inhibitor of c-src for preventing or treating synucleinopathy" (South Korean Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,892, issued on March 4, was assigned to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Suwon-si, South Korea).

"Pharmaceutical composition comprising expression or activity inhibitor of c-src for preventing or treating synucleinopathy" was invented by Sang Myun Park (Suwon-si, South Korea), Yu Ree Choi (Suwon-si, South Korea) and Jae Bong Kim (Busan, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition including a substance that inhibits an expression or activity of c-src and its use in inhibiting aggregation and/or migration of Alpha-syn are disclosed. The composition may be a pharmaceutical composition and can be use...